title: Incorporation and distribution of strontium in bone.
abstract: The distribution and incorporation of strontium into bone has been examined in rats, monkeys, and humans after oral administration of strontium (either strontium chloride or strontium ranelate). After repeated administration for a sufficient period of time (at least 4 weeks in rats), strontium incorporation into bone reaches a plateau level. This plateau appears to be lower in females than in males due to a difference in the absorption process. Steady-state plasma strontium levels are reached more rapidly than in bones, and within 10 days in the rat. The strontium levels in bone vary according to the anatomical site. However, strontium levels at different skeletal sites are strongly correlated, and the strontium content of the lumbar vertebra may be estimated from iliac crest bone biopsies in monkeys. The strontium levels in bone also vary according to the bone structure and higher amounts of strontium are found in cancellous bone than in cortical bone. Furthermore, at the crystal level, higher concentrations of strontium are observed in newly formed bone than in old bone. After withdrawal of treatment, the bone strontium content rapidly decreases in monkeys. The relatively high clearance rate of strontium from bone can be explained by the mechanisms of its incorporation. Strontium is mainly incorporated by exchange onto the crystal surface. In new bone, only a few strontium atoms may be incorporated into the crystal by ionic substitution of calcium. After treatment withdrawal, strontium exchanged onto the crystal is rapidly eliminated, which leads to a rapid decrease in total bone strontium levels. In summary, incorporation of strontium into bone, mainly by exchange onto the crystal surface, is dependent on the duration of treatment, dose, gender, and skeletal site. Nevertheless, bone strontium content is highly correlated with plasma strontium levels and, in bone, between the different skeletal sites.
authors.affiliation: Department of Pharmacology, Faculty of Medicine, University of, Tromsø, Tromsø, Norway. sgd@fagmed.uit.no
authors.forename: S G
authors.initials: SG
authors.lastname: Dahl
authors.forename: P
authors.initials: P
authors.lastname: Allain
authors.forename: P J
authors.initials: PJ
authors.lastname: Marie
authors.forename: Y
authors.initials: Y
authors.lastname: Mauras
authors.forename: G
authors.initials: G
authors.lastname: Boivin
authors.forename: P
authors.initials: P
authors.lastname: Ammann
authors.forename: Y
authors.initials: Y
authors.lastname: Tsouderos
authors.forename: P D
authors.initials: PD
authors.lastname: Delmas
authors.forename: C
authors.initials: C
authors.lastname: Christiansen
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001842:Bone and Bones / Q000378:metabolism*; D005260:Female; D006801:Humans; D008252:Macaca fascicularis; D008297:Male; D051381:Rats; D012737:Sex Factors; D013324:Strontium / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D013324:Strontium